Nika Adham

5.4k citations

60 papers · 3.8k indexed · 1 hit paper · h-index 27

Impact in

Cellular and Molecular Neuroscience top 0.5%
- Neurotransmitter Receptor Influence on Behavior
- Neuroscience and Neuropharmacology Research
- Neuropeptides and Animal Physiology
Biological Psychiatry top 2%

Papers in

Cellular and Molecular Neuroscience 52
- Neurotransmitter Receptor Influence on Behavior 38
- Neuroscience and Neuropharmacology Research 17
- Neuropeptides and Animal Physiology 10
Biological Psychiatry 3

Co-authors: Richard L. Weinshank T. A. Branchek Paul Hartig Jonathan Bard Béla Kiss J M Zgombick Theresa A. Branchek P J Vaysse
Journals: Molecular Pharmacology (5 papers)Psychopharmacology (5 papers)Journal of Pharmacology and Experimental Therapeutics (4 papers)Neuropharmacology (4 papers)European Neuropsychopharmacology (4 papers)
Partner nations: United States Hungary United Kingdom

In The Last Decade

Nika Adham

60 papers receiving 3.7k citations

Hit Papers

align trajectories log scale

Trace amines: Identification of a family of mammalian G protein-coupled receptors 2001 · 689 citations

Peers

Countries citing papers authored by Nika Adham

Since Specialization

Citations

This map shows the geographic impact of Nika Adham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nika Adham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nika Adham more than expected).

Fields of papers citing papers by Nika Adham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nika Adham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nika Adham. The network helps show where Nika Adham may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Nika Adham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nika Adham Line = papers co-authored together Nika Adham links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The Role of Dopamine D3 Receptor Partial Agonism in Cariprazine-Induced Neurotransmitter Efflux in Rat Hippocampus and Nucleus Accumbens Journal of Pharmacology and Experimental Therapeutics ·Mei Huang, M. M�ller, Béla Kiss, 久貴福島, Nika Adham, Herbert Y. Meltzer	2019	23
2	The Effects of Cariprazine and Aripiprazole on PCP-Induced Deficits on Attention Assessed in the 5-Choice Serial Reaction Time Task Psychopharmacology ·Samuel A. Barnes, Jared W. Young, Athina Markou, Nika Adham, István Gyertyán, Béla Kiss	2018	16
3	Long-term effects of aripiprazole exposure on monoaminergic and glutamatergic receptor subtypes: comparison with cariprazine CNS Spectrums ·Yong Kee Choi, Nika Adham, Béla Kiss, István Gyertyán, Frank I. Tarazi	2017	16
4	Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3/D2 receptor ligand [11C]-(+)-PHNO Psychopharmacology ·Ragy R. Girgis, Mark Slifstein, Deepak Cyril D’Souza, Kai Wang, Antonia Periclou, Parviz Ghahramani, I. Laszlovszky, Suresh Durgam, Nika Adham, Nabeel Nabulsi, Yiyun Huang, Richard E. Carson, Béla Kiss, Margit Kapás, Anissa Abi‐Dargham, Ashok Rakhit	2016	97
5	The dopamine D 3 -preferring D 2 /D 3 dopamine receptor partial agonist, cariprazine, reverses behavioural changes in a rat neurodevelopmental model for schizophrenia European Neuropsychopharmacology ·David J. Watson, Madeleine V. King, István Gyertyán, Béla Kiss, Nika Adham, K.C.F. Fone	2015	45
6	Attenuation of anhedonia by cariprazine in the chronic mild stress model of depression Behavioural Pharmacology ·Mariusz Papp, Piotr Gruca, Magdalena Łasoń, Nika Adham, Béla Kiss, István Gyertyán	2014	65
7	Cariprazine, a dopamine D3-receptor-preferring partial agonist, blocks phencyclidine-induced impairments of working memory, attention set-shifting, and recognition memory in the mouse Psychopharmacology ·Stephenie L. Richards, Gloria Chang, István Gyertyán, Béla Kiss, Nika Adham, Claudia Schmauss	2012	84
8	Identification and Characterization of Two Neuromedin U Receptors Differentially Expressed in Peripheral Tissues and the Central Nervous System Journal of Biological Chemistry ·Rita Raddatz, R H Ariff, Roman Artymyshyn, James A. Bonini, Beth Borowsky, Lakmal W. Boteju, Samah Daffalla, Evguenia Kouranova, Nadya Y. Ahmed, Mauro Adriel Ríos Villacorta, Meng Dai, Sibi T. Baby, Pierre J.‐J. Vaysse, Theresa A. Branchek, Christophe Gerald, Carlos Forray, Nika Adham	2000	170
9	[ 3 H]RS 57639, a High Affinity, Selective 5-HT 4 Receptor Partial Agonist, Specifically Labels Guinea-pig Striatal and Rat Cloned (5-HT 4S and 5-HT 4L ) Receptors Neuropharmacology ·Douglas W. Bonhaus, Joel G. Berger, Nika Adham, T. A. Branchek, C. W. S., Dana N. Loury, Edward Leung, Erik H.F. Wong, Robin D. Clark, Richard M. Eglen	1997	8
10	Cloning and Characterization of The Guinea Pig 5-HT 1F Receptor Subtype: a Comparison of the Pharmacological Profile to the Human Species Homolog Neuropharmacology ·Nika Adham, Jonathan Bard, J M Zgombick, Margaret M. Durkin, Amir lashkari, Richard L. Weinshank, T. A. Branchek	1997	40
11	5-HT1F receptor agonists inhibit neurogenic dural inflammation in guinea pigs Neuroreport ·Kirk W. Johnson, John M. Schaus, Margaret M. Durkin, James E. Audia, Stephen W. Kaldor, Michael E. Flaugh, Nika Adham, John M. Zgombick, Marlene L. Cohen, Theresa A. Branchek, Lee A. Phebus	1997	128
12	Modeling the G-protein-coupled neuropeptide Y Y1 receptor agonist and antagonist binding sites Protein Engineering Design and Selection ·Ping Du, John Salon, Joseph A. Tamm, Cuifen Hou, Weili Cui, Mary W. Walker, Nika Adham, Cristina Reichner, Imadul Islam, P J Vaysse, Takashi FUKU, Melissa A. Savas, Makitalo, H. Rüeger, B. N. Udodov, Yuki Yamaguchi, T. A. Branchek, R. L. Weinshank, Charles Gluchowski	1997	48
13	Pharmacological characterizations of recombinant human 5-HT1D1D? and 5-HT1D? receptor subtypes coupled to adenylate cyclase inhibition in clonal cell lines: apparent differences in drug intrinsic efficacies between human 5-HT1D subtypes Naunyn-Schmiedeberg s Archives of Pharmacology ·J M Zgombick, Eka Sandra Amelia Sari, Nika Adham, Amir lashkari, C. L. Stanton, 송태은	1996	26
14	Pharmacological characterization of the recombinant human 5-HT-7 receptor subtype coupled to adenylate cyclase stimulation in a clonal cell line The Society for Neuroscience Abstracts ·J M Zgombick, Nika Adham, Jonathan Bard, P J Vaysse, R. L. Weinshank, T. A. Branchek	1995	3
15	A single point mutation increases the affinity of serotonin 5-HT1Dα, 5-HT1Dβ, 5-HT1E and 5-HT1F receptors for β-adrenergic antagonists Neuropharmacology ·Nika Adham, Joseph A. Tamm, John Salon, Dohwi Choi, Richard L. Weinshank, T. A. Branchek	1994	43
16	The cloned human 5-HT1E receptor couples to inhibition and activation of adenylyl cyclase via two distinct pathways in transfected BS-C-1 cells Neuropharmacology ·Nika Adham, Dohwi Choi, Richard L. Weinshank, T. A. Branchek	1994	17
17	Cell-specific coupling of the cloned human 5-HT1F receptor to multiple signal transduction pathways Naunyn-Schmiedeberg s Archives of Pharmacology ·Nika Adham, Laurence A. Borden, Lee E. Schechter, Eric L. Gustafson, N Mabrodinov, Dohwi Choi, Richard L. Weinshank, Theresa A. Branchek	1993	50
18	Serotonin Receptor Subtypes PubMed ·Paul Hartig, Nika Adham, J M Zgombick, M Macchi, Hung‐Teh Kao, Lee E. Schechter, T. A. Branchek, Richard L. Weinshank	1993	10
19	Acute desensitization of muscarinic receptors in the isolated guinea‐pig ileal longitudinal muscle Journal of Autonomic Pharmacology ·Richard M. Eglen, Nika Adham, R.L. Whiting	1992	17
20	Cloning, expression, and pharmacological characterization of a human alpha 2B-adrenergic receptor. Molecular Pharmacology ·Richard L. Weinshank, J M Zgombick, M Macchi, Nika Adham, H. Lichtblau, T A Branchek, Paul Hartig	1990	95

About Nika Adham

Nika Adham is a scholar working on Cellular and Molecular Neuroscience, Biological Psychiatry, Psychiatry and Mental health, Behavioral Neuroscience and Molecular Biology, having authored 60 papers that have together received 3.8k indexed citations. Recurring topics across this work include Neurotransmitter Receptor Influence on Behavior (38 papers), Receptor Mechanisms and Signaling (30 papers), Neuroscience and Neuropharmacology Research (17 papers), Ion channel regulation and function (10 papers), Neuropeptides and Animal Physiology (10 papers), Neuroendocrine regulation and behavior (7 papers), Nicotinic Acetylcholine Receptors Study (6 papers) and Schizophrenia research and treatment (6 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (2.4k citations), Biological Psychiatry (174 citations), Psychiatry and Mental health (873 citations), Sensory Systems (156 citations) and Endocrine and Autonomic Systems (216 citations). Nika Adham has collaborated with scholars based in United States, Hungary and United Kingdom. Frequent co-authors include Richard L. Weinshank, T. A. Branchek, Paul Hartig, Jonathan Bard, Béla Kiss, J M Zgombick, Theresa A. Branchek, P J Vaysse, István Gyertyán and Margaret M. Durkin. Their work appears in journals such as Molecular Pharmacology, Psychopharmacology, Journal of Pharmacology and Experimental Therapeutics, Neuropharmacology and European Neuropsychopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact